
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.25 | -8.68055555556 | 2.88 | 3 | 2.61 | 56317 | 2.81183892 | CS |
4 | -0.55 | -17.2955974843 | 3.18 | 3.1993 | 2.46 | 72541 | 2.88710041 | CS |
12 | -0.45 | -14.6103896104 | 3.08 | 4.3866 | 2.46 | 100106 | 3.45152197 | CS |
26 | 0.29 | 12.3931623932 | 2.34 | 4.3866 | 2.11 | 63179 | 3.18079973 | CS |
52 | -0.33 | -11.1486486486 | 2.96 | 4.3866 | 1.75 | 48242 | 2.9217689 | CS |
156 | -6.7 | -71.8113612004 | 9.33 | 20.65 | 1.75 | 93137 | 8.41370099 | CS |
260 | -8.92 | -77.2294372294 | 11.55 | 20.65 | 1.75 | 94117 | 8.44725444 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions